These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8175446)
1. Multivariate determinants of radiocurability. I: Prediction of single fraction tumor control doses. Gerweck LE; Zaidi ST; Zietman A Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):57-66. PubMed ID: 8175446 [TBL] [Abstract][Full Text] [Related]
2. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma. Murata R; Nishimura Y; Hiraoka M Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820 [TBL] [Abstract][Full Text] [Related]
3. Local tumor control following single dose irradiation of human melanoma xenografts: relationship to cellular radiosensitivity and influence of an immune response by the athymic mouse. Rofstad EK Cancer Res; 1989 Jun; 49(12):3163-7. PubMed ID: 2655893 [TBL] [Abstract][Full Text] [Related]
4. Influence of cellular radiation sensitivity on local tumor control of human melanoma xenografts given fractionated radiation treatment. Rofstad EK Cancer Res; 1991 Sep; 51(17):4609-12. PubMed ID: 1873806 [TBL] [Abstract][Full Text] [Related]
5. Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction. Milas L; Hunter N; Peters LJ Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):139-42. PubMed ID: 2912935 [TBL] [Abstract][Full Text] [Related]
6. Impact of stromal sensitivity on radiation response of tumors. Budach W; Taghian A; Freeman J; Gioioso D; Suit HD J Natl Cancer Inst; 1993 Jun; 85(12):988-93. PubMed ID: 8496984 [TBL] [Abstract][Full Text] [Related]
7. Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations. Bristow RG; Hill RP Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):331-45. PubMed ID: 2303364 [TBL] [Abstract][Full Text] [Related]
8. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation. Baumann M; DuBois W; Pu A; Freeman J; Suit HD Int J Radiat Oncol Biol Phys; 1992; 23(4):803-9. PubMed ID: 1319979 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status. Evans SM; Jenkins WT; Shapiro M; Koch CJ Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430 [TBL] [Abstract][Full Text] [Related]
10. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma. Kuroda M; Urano M; Nishimura Y; Reynolds R Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330 [TBL] [Abstract][Full Text] [Related]
11. The proportion of stem cells in murine tumors. Hill RP; Milas L Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):513-8. PubMed ID: 2921157 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide. Milas L; Nakayama T; Hunter N; Jones S; Lin TM; Yamada S; Thames H; Peters L Radiother Oncol; 1994 Mar; 30(3):247-53. PubMed ID: 8209009 [TBL] [Abstract][Full Text] [Related]
13. Single dose radiocurability of four murine solid tumors and a predictive assay for the curability in situ. Takai Y; Hosoi Y; Sakamoto K; Okada S J Radiat Res; 1997 Dec; 38(4):233-40. PubMed ID: 9558826 [TBL] [Abstract][Full Text] [Related]
14. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Sun JR; Brown JM Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067 [TBL] [Abstract][Full Text] [Related]
15. [Predictive tests of radiocurability: towards a custom-made radiotherapy?]. Cosset JM; Peters LJ; Girinsky T; Guichard M; Eschwege F; Mornex F; Malaise EP Bull Cancer Radiother; 1990; 77(2):83-94. PubMed ID: 8703551 [TBL] [Abstract][Full Text] [Related]
16. [Radiosensitivity of the murine NKLy solid tumor and recovery of clonogenic cells from potentially lethal radiation damage]. Gulverdashvili NA; Afanas'ev GG; Pelevina II Radiobiologiia; 1985; 25(5):713-6. PubMed ID: 4070582 [TBL] [Abstract][Full Text] [Related]
17. Correlations between in vivo 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy. Fu KK; Wendland MF; Iyer SB; Lam KN; Engeseth H; James TL Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1341-50. PubMed ID: 2370183 [TBL] [Abstract][Full Text] [Related]
18. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543 [TBL] [Abstract][Full Text] [Related]
19. Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159. Peters LJ Br J Radiol; 1976 Aug; 49(584):708-15. PubMed ID: 953390 [TBL] [Abstract][Full Text] [Related]
20. Energy status parameters, hypoxia fraction and radiocurability across tumor types. Gerweck LE; Koutcher J; Zaidi ST Acta Oncol; 1995; 34(3):335-8. PubMed ID: 7779419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]